Annual EBIT:
-$51.52M-$17.60M(-51.89%)Summary
- As of today, TRVI annual earnings before interest & taxes is -$51.52 million, with the most recent change of -$17.60 million (-51.89%) on December 31, 2024.
- During the last 3 years, TRVI annual EBIT has fallen by -$19.05 million (-58.65%).
Performance
TRVI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$13.72M-$2.25M(-19.63%)Summary
- As of today, TRVI quarterly earnings before interest & taxes is -$13.72 million, with the most recent change of -$2.25 million (-19.63%) on June 30, 2025.
- Over the past year, TRVI quarterly EBIT has dropped by -$433.00 thousand (-3.26%).
- TRVI quarterly EBIT is now -517.55% below its all-time high of -$2.22 million, reached on December 1, 2017.
Performance
TRVI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$51.52M-$433.00K(-0.85%)Summary
- As of today, TRVI TTM earnings before interest & taxes is -$51.52 million, with the most recent change of -$433.00 thousand (-0.85%) on June 30, 2025.
- Over the past year, TRVI TTM EBIT has dropped by -$8.35 million (-19.34%).
- TRVI TTM EBIT is now -2218.72% below its all-time high of -$2.22 million, reached on December 1, 2017.
Performance
TRVI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TRVI EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -51.9% | -3.3% | -19.3% |
| 3Y3 Years | -58.6% | -75.5% | -71.4% |
| 5Y5 Years | -93.4% | -85.1% | -71.4% |
TRVI EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -72.1% | at low | -106.1% | +2.6% | -72.3% | +0.0% |
| 5Y | 5-Year | -93.4% | at low | -106.1% | +2.6% | -72.3% | +0.0% |
| All-Time | All-Time | >-9999.0% | at low | -517.5% | +2.6% | -2218.7% | +0.0% |
TRVI EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$13.72M(-19.6%) | -$51.52M(-0.8%) |
| Mar 2025 | - | -$11.47M(+6.3%) | -$51.09M(+0.8%) |
| Dec 2024 | -$51.52M(-51.9%) | -$12.24M(+13.1%) | -$51.52M(-6.9%) |
| Sep 2024 | - | -$14.09M(-6.0%) | -$48.22M(-11.7%) |
| Jun 2024 | - | -$13.29M(-11.6%) | -$43.17M(-12.8%) |
| Mar 2024 | - | -$11.91M(-33.3%) | -$38.27M(-12.8%) |
| Dec 2023 | -$33.92M(-13.3%) | -$8.93M(+1.2%) | -$33.92M(-7.2%) |
| Sep 2023 | - | -$9.04M(-7.9%) | -$31.65M(-2.1%) |
| Jun 2023 | - | -$8.38M(-10.8%) | -$31.01M(-1.8%) |
| Mar 2023 | - | -$7.56M(-13.6%) | -$30.45M(-1.8%) |
| Dec 2022 | -$29.94M(+7.8%) | -$6.66M(+20.8%) | -$29.91M(+5.1%) |
| Sep 2022 | - | -$8.40M(-7.5%) | -$31.52M(-4.8%) |
| Jun 2022 | - | -$7.82M(-11.3%) | -$30.07M(+4.3%) |
| Mar 2022 | - | -$7.03M(+15.1%) | -$31.41M(+3.3%) |
| Dec 2021 | -$32.48M | -$8.27M(-19.1%) | -$32.48M(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$6.95M(+24.2%) | -$33.40M(+0.9%) |
| Jun 2021 | - | -$9.17M(-13.3%) | -$33.69M(-5.5%) |
| Mar 2021 | - | -$8.09M(+12.0%) | -$31.94M(+1.7%) |
| Dec 2020 | -$32.49M(-21.9%) | -$9.19M(-26.9%) | -$32.49M(-8.1%) |
| Sep 2020 | - | -$7.24M(+2.3%) | -$30.06M(+1.3%) |
| Jun 2020 | - | -$7.41M(+14.2%) | -$30.47M(+0.0%) |
| Mar 2020 | - | -$8.64M(-27.7%) | -$30.47M(-14.4%) |
| Dec 2019 | -$26.64M(-44.7%) | -$6.77M(+11.6%) | -$26.64M(-3.2%) |
| Sep 2019 | - | -$7.65M(-3.1%) | -$25.81M(-42.1%) |
| Jun 2019 | - | -$7.42M(-54.1%) | -$18.16M(-20.1%) |
| Mar 2019 | - | -$4.81M(+18.8%) | -$15.12M(-46.7%) |
| Dec 2018 | -$18.41M(>-9900.0%) | -$5.93M(-35.4%) | -$10.31M(-56.1%) |
| Jun 2018 | - | -$4.38M(-97.1%) | -$6.60M(-197.1%) |
| Dec 2017 | $0.00(+100.0%) | - | - |
| Dec 2017 | - | -$2.22M | -$2.22M |
| Dec 2016 | -$8.63M | - | - |
FAQ
- What is Trevi Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. annual EBIT year-on-year change?
- What is Trevi Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Trevi Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. TTM EBIT year-on-year change?
What is Trevi Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of TRVI is -$51.52M
What is the all-time high annual EBIT for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high annual earnings before interest & taxes is $0.00
What is Trevi Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, TRVI annual earnings before interest & taxes has changed by -$17.60M (-51.89%)
What is Trevi Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of TRVI is -$13.72M
What is the all-time high quarterly EBIT for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$2.22M
What is Trevi Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, TRVI quarterly earnings before interest & taxes has changed by -$433.00K (-3.26%)
What is Trevi Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of TRVI is -$51.52M
What is the all-time high TTM EBIT for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$2.22M
What is Trevi Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, TRVI TTM earnings before interest & taxes has changed by -$8.35M (-19.34%)